← Open Payments lookup

CAROLYN HARRIS-MUCHELL: Open Payments

NPI 1619155280 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,045 in 12 payments from 8 companies in 2025. Trend: 2023 $387 · 2024 $713 · 2025 $1,045

Food & beverage: $1,018Education: $27
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$294
Alkermes, Inc.2$203
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$143
Otsuka America Pharmaceutical, Inc.1$124
Teva Pharmaceuticals USA, Inc.1$122
Neurocrine BioSciences, Inc.1$110
E.R. Squibb & Sons, L.L.C.1$27
Supernus Pharmaceuticals, Inc.1$21

Products named: INVEGA SUSTENNA, CAPLYTA, UZEDY, ARISTADA, INGREZZA, LYBALVI, COBENFY, Qelbree.

Industry payments across CA — which companies pay providers there.